1. Home
  2. KYMR vs HII Comparison

KYMR vs HII Comparison

Compare KYMR & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$110.28

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

HOLD

Current Price

$287.84

Market Cap

11.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
HII
Founded
2015
1886
Country
United States
United States
Employees
N/A
44000
Industry
Medicinal Chemicals and Botanical Products
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.5B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
KYMR
HII
Price
$110.28
$287.84
Analyst Decision
Strong Buy
Buy
Analyst Count
26
6
Target Price
$107.72
$411.33
AVG Volume (30 Days)
682.9K
398.8K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
1.52%
EPS Growth
N/A
10.24
EPS
N/A
3.79
Revenue
$39,211,000.00
$12,484,000,000.00
Revenue This Year
$10.61
$4.82
Revenue Next Year
$8.17
$6.28
P/E Ratio
N/A
$75.88
Revenue Growth
N/A
8.23
52 Week Low
$36.88
$256.45
52 Week High
$130.05
$460.00

Technical Indicators

Market Signals
Indicator
KYMR
HII
Relative Strength Index (RSI) 54.52 53.40
Support Level $108.87 $287.43
Resistance Level $120.90 $298.57
Average True Range (ATR) 5.47 6.91
MACD -1.68 1.91
Stochastic Oscillator 22.52 79.92

Price Performance

Historical Comparison
KYMR
HII

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: